日本大学病院は、東京都千代田区にある医療機関であり、学校法人日本大学が運営する病院である。略称は日大病院。

During the past decade, Surugadai Nihon university hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Surugadai Nihon university hospital" #1 sponsor was "Japan Clinical Cancer Research Organization" with 3 trials, followed by "Nihon University" with 2 trials sponsored, "National Cerebral and Cardiovascular Center" with 1 trials sponsored, "Ophthalmic PDT Study Group" with 1 trials sponsored and "Osaka City University" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Surugadai Nihon university hospital" #1 collaborator was "Fukuoka Kinen Hospital" with 1 trials as a collaborator, "Kimura Eye and Internal Medicine Hospital" with 1 trials as a collaborator, "Kitasato University" with 1 trials as a collaborator, "Korean Cancer Study Group" with 1 trials as a collaborator and "Kurume University" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Surugadai Nihon university hospital" are "Gastric Cancer" (3 trials), "Age Related Macular Degeneration" (1 trials), "Age-related Macular Degeneration" (1 trials), "Cardiac Arrest" (1 trials) and "Diabetic Traction Retinal Detachment" (1 trials). Many other conditions were trialed in "Surugadai Nihon university hospital" in a lesser frequency.

Most popular intervention types in "Surugadai Nihon university hospital" are "Drug" (5 trials), "Procedure" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "S-1" (2 trials), "Aflibercept" (1 trials), "Bevacizumab" (1 trials), "Ocular photodynamic therapy with verteporfin" (1 trials) and "S-1 + irinotecan" (1 trials). Other intervention names were less common.

The vast majority of trials in "Surugadai Nihon university hospital" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Surugadai Nihon university hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Surugadai Nihon university hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Surugadai Nihon university hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".